About Us
Dedicated to be an exquisite specialized pharmaceutical research companyWings with Innovation, Strength, Thinking and AspirationBeijing Wista Pharma Co., Ltd, founded in 2009, is located in Beijing Economic-Technological Development Area, committed to independent research and authorized production for chemical innovative drugs and high-end generic drugs.Our laboratory area is more than 2000 square meters, which has passed the environmental assessment, fire protection and safety assessment in Beijing, is equipped with a series of precise instruments, like, high performance liq...
Technical Service
News
- Company News |
- Industry News
Luliconazole and posaconazole are launched into market
The synthesis pilots of Luliconazole and posaconazole are successfully completed.The key intermediates are available to international market from July 2013.
Olopatadine hydrochloride tablets has been approved by China SF
Our new formulation Olopatadine hydrochloride tablets (5mg ) has been approved by China SFDA on 31st May 2022. The tablets registration certificate No. is H20213892 and ...
Voriconazole tablets has been approved by China SF
Our new formulation Voriconazole tablets (50mg and 200mg) has been approved by China SFDA on 24th Nov. 2021. The tablets registration certificate No. is H20213892 and H20...